Skip to main content

Year: 2021

High construction activity resulted in solid Q3 sales growth, with soaring energy prices requiring additional price increases.

Report on the first nine months of 2021for ROCKWOOL International A/SRelease no. 21 – 2021to Nasdaq Copenhagen 24 November 2021 High construction activity resulted in solid Q3 sales growth, with soaring energy prices requiring additional price increases. HighlightsSales in the first nine months of 2021 reached 2 246 MEUR, an increase of 19 percent in local currencies and 18 percent in reported figures. Sales in Q3 2021 reached 797 MEUR, a growth of 18 percent in local currencies compared to Q3 2020, driven by high volume demand and sales price increases. EBITDA in the first nine months of 2021 reached 456 MEUR, with a 20.3 percent EBITDA margin, up 0.6 percentage points from last year. Strong leverage from sales growth contributed to the result. EBITDA in Q3 2021 reached 157 MEUR, with a 19.7 percent EBITDA margin, down 2.0 percentage...

Continue reading

MT Højgaard Holding A/S: Enemærke & Petersen wins strategic partnership with Copenhagen Municipality

MT Højgaard Holding’s business unit, Enemærke & Petersen, has won Copenhagen Municipality’s tender for a 4-year strategic partnership for renovation and new construction projects in the children and youth area, expecting to continue the good cooperation from 2016 between the Municipality and the partners of the TRUST consortium. Copenhagen Municipality is expected to enter into the agreement with Enemærke & Petersen after expiration of the standstill period. The Municipality expects revenue from the strategic partnership to amount to approximately DKK 2.5 billion over the 4-year period. Enemærke & Petersen will perform the work in close cooperation with the TRUST partners: Kant Arkitekter, Nøhr & Sigsgaard, Dominia, Norconsult, Lytt Architecture and Kragh & Berglund. The new partnership is a continuation of the...

Continue reading

GOGL – Q3 2021 Presentation

Please find enclosed the presentation of Golden Ocean Group Limited’s third quarter 2021 results for today’s webcast / conferance call at 15:00 CET. Attend by Webcast: Use to the follow link prior to the webcast: https://edge.media-server.com/mmc/p/bzj9zg4c Attend by Conference Call: Applicable dial-in telephone numbers are as follows:International Dial-In: +44 (0) 2071 92 8000United Kingdom Toll Free: 08003767922Norway Toll Free: 800 51 874US Toll-Free: +1 866 966 1396The presentation material which will be used in the teleconference/webcast can be downloaded on www.goldenocean.bm and replay details will also be available at this website. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act  Attachment...

Continue reading

XPO Logistics Hosts Women in Leadership Conference for Inaugural XPO RISE Participants

Introduces executive training program to increase gender diversity GREENWICH, Conn., Nov. 24, 2021 (GLOBE NEWSWIRE) — XPO Logistics, Inc. (NYSE: XPO), a leading provider of freight transportation services, held its inaugural Women in Leadership Conference in Atlanta on November 17-19. The event is part of XPO RISE, the company’s executive training program for high-potential female managers. The company introduced XPO RISE this year to increase the gender diversity of its top talent in North America. The 18 women selected for the program represent a range of managerial functions within XPO, including technology, sales operations, project management and customer service. All attended the Women in Leadership Conference. Featured speakers included XPO leaders LaQuenta Jacobs, chief diversity officer; Tanya Stokoe, senior vice president,...

Continue reading

VSBLTY, 911inform Make First Deployment of ‘Total Solutions’ Security Software

Advanced Security Technology Can Provide Incident Data to 911, First Responders Anywhere in U.S. Philadelphia, PA, Nov. 24, 2021 (GLOBE NEWSWIRE) — VSBLTY Groupe Technologies Corp. (OTCQB: VSBGF) (CSE: VSBY) (Frankfurt 5VS) (“VSBLTY”), a leading software provider of security and retail analytics technology, today announced that a joint system integration with 911inform has been completed, tested, and deployed to multiple customers across the United States. The “Total Security Platform” provides police, first responders and local onsite personnel with the ability to access data instantly and gain situational awareness from VSBLTY’s industry leading Vector™ software through its partnership with 911inform. The VSBLTY/911inform combined technology provides a custom protection layer around the clients’ facilities to automatically detect...

Continue reading

Global Gene Therapy Market Size 2021-2028, Share, Growth Factors, Trends, Revenue, Competitive Landscape, Forecast

Key Companies in Gene Therapy Market are Novartis AG, Spark Therapeutics, Inc., Biogen, Gilead Sciences, Inc, Amgen, Inc., Jazz Pharmaceuticals, Inc., Sarepta Therapeutics, GlaxoSmithKline plc, Other Prominent Players Pune, India, Nov. 24, 2021 (GLOBE NEWSWIRE) — The global gene therapy market is set to gain momentum from the rising incidence of different types of cancer. The field of this therapy is undergoing several technological advancements that would help in treating cancer in those patients who are at high risks of getting affected by this disease through genetic mutations. Fortune Business Insights™ provided this information in a new report, titled, “Gene Therapy Market Size, Share & COVID-19 Impact Analysis, By Application (Oncology, Neurology, and Others), By Vector Type (Viral and Non-viral), By Distribution Channel...

Continue reading

Nordic American Tankers Ltd (NYSE: NAT) – Third quarter 2021. Third quarter touched the bottom. The tide has now turned.

Wednesday, November 24, 2021  Dear Shareholders and Investors,    Please see HIGHLIGHTS and enclosed 3Q 2021 report below.   HIGHLIGHTS:   There is so much confusing day-to-day noise in the markets about oil and gas prices that we think many investors have decided to steer clear of the tanker sector entirely. All markets are volatile, and as history has shown volatility can be our friend when rates rise suddenly and the company’s stock price benefits. We firmly believe that successful investors buy quality companies and profit handsomely when the tide turns.A main feature of the NAT strategy is that NAT has suezmaxes only. No other public company has this feature. Asset values continue to rise.The International Energy Agency in Paris confirms that global oil demand is nearing pre-pandemic levels of early 2020 and more importantly,...

Continue reading

Mesa Air Group Announces Fourth Quarter and Fiscal Year 2021 Earnings Release and Conference Call Date

PHOENIX, Nov. 24, 2021 (GLOBE NEWSWIRE) — Mesa Air Group, Inc. (NASDAQ: MESA) will release its 2021 fourth quarter and fiscal year end earnings after the market closes on Thursday, December 9. The company will also host a conference call to discuss the results on December 9th at 4:30 pm Eastern Time. The call can be accessed by dialing 888-469-2054 and entering the passcode: PHOENIX (7463649). There will also be a listen-only webcast on Mesa’s website (http://investor.mesa-air.com/events-and-presentations/events). A recorded version will be available on Mesa’s website approximately two hours after the call (http://investor.mesa-air.com). About Mesa Air Group, Inc. Headquartered in Phoenix, Arizona, Mesa Air Group, Inc. is the holding company of Mesa Airlines, a regional air carrier providing scheduled passenger service to 129 cities...

Continue reading

Algernon Pharmaceuticals Announces Positive Feedback from U.S. FDA for Phase 1 Ifenprodil Small Cell Lung Cancer Study

VANCOUVER, British Columbia, Nov. 24, 2021 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) a clinical stage pharmaceutical development company, is pleased to announce that it has received positive feedback from the U.S. Food and Drug Administration (U.S. FDA) at its pre-IND (Investigational New Drug) meeting for its investigation of NP-120 (Ifenprodil) for the treatment of small cell lung cancer (SCLC). Ifenprodil is an N-methyl-D-aspartate (NMDA) receptor antagonist specifically targeting the NMDA-type subunit 2B (GluN2B). As a result of the feedback, the Company is not planning to conduct any additional pre-clinical research and will immediately move to file an IND application to begin its Phase 1 SCLC study as soon as possible. Based on the feedback from...

Continue reading

Mirasol Resources Announces Start of Drilling at Gorbea and Provides Exploration Update

VANCOUVER, British Columbia, Nov. 24, 2021 (GLOBE NEWSWIRE) — Mirasol Resources Ltd. (TSX-V: MRZ) (OTCPK: MRZLF) (the “Company” or “Mirasol”) today provided an update on exploration plans for the current field season and is also pleased to report that drilling has commenced at its Newcrest-partnered Gorbea Au project in Northern Chile. Tim Heenan, Mirasol’s President stated: “We have made excellent progress on our self-funded and partnered projects and are off to a very strong start this field season. Drilling is currently underway at our partnered projects Gorbea, Nord and Virginia. We are very excited to be preparing for a maiden ground exploration program at our self-funded Sobek project to follow up on compelling magnetic features identified in the recently completed aeromagnetic survey. We are also currently conducting a deep-penetrating...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.